These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20001575)

  • 21. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
    Mateos V; Roig C; López Rodríguez I; López-Gil A
    Neurologia; 2002 Dec; 17(10):621-7. PubMed ID: 12487957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do patients want from acute migraine treatment?
    Gallagher R
    Cephalalgia; 2004; 24 Suppl 2():8-15. PubMed ID: 15595989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
    Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
    Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries.
    Morillo LE; Alarcon F; Aranaga N; Aulet S; Chapman E; Conterno L; Estevez E; Garcia-Pedroza F; Garrido J; Macias-Islas M; Monzillo P; Nunez L; Plascencia N; Rodriguez C; Takeuchi Y;
    Headache; 2005 Feb; 45(2):118-26. PubMed ID: 15705116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment guidelines for acute migraine attacks].
    Treatment Guideline Subcommittee of Taiwan Headache Society
    Acta Neurol Taiwan; 2007 Dec; 16(4):251-68. PubMed ID: 18220021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT Study).
    Lantéri-Minet M; Massiou H; Romatet S; Barba A; Lucas C; Allaf B
    Headache; 2011 Apr; 51(4):590-601. PubMed ID: 21457243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
    Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
    Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Migraine or headache management: a pharmacy survey].
    Desamericq G; Revol A; Laforest L; Chamba G; Bauguil G; Ritleng C; Van Ganse E
    Therapie; 2009; 64(6):395-403. PubMed ID: 20025843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective).
    Rozen TD
    Headache; 2006 May; 46(5):750-3. PubMed ID: 16643577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache.
    Moore KL; Noble SL
    Am Fam Physician; 1997 Nov; 56(8):2039-48, 2051-4. PubMed ID: 9390098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Almotriptan in triptan-naïve patients: new evidence of benefits.
    Pascual J
    Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical care perceptions in elderly patients with musculoskeletal complaints.
    Hershkovitz A; Rothschild BM; Rose JH; Hornick T; O'Toole EE
    Isr Med Assoc J; 2001 Nov; 3(11):822-7. PubMed ID: 11729577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of the burden of migraine using the willingness to pay model.
    Hamelsky SW; Lipton RB; Stewart WF
    Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
    Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S
    Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migraine changes with age: IMPACT on migraine classification.
    Kelman L
    Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
    Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
    Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.